The Dawn of a New Era: Targeting the "Undruggables" with Antibody-Based Therapeutics

Release Time:2024-03-31 Hits:

Indexed by:Journal Papers

Document Code:371273

Date of Publication:2023-05-15

Journal:CHEMICAL REVIEWS

Volume:123

Issue:12

Page Number:7782-7853

ISSN:0009-2665

Key Words:BLOOD-BRAIN-BARRIER; CELL-PENETRATING PEPTIDES; DIRECT CYTOSOLIC DELIVERY; DRUG CONJUGATES ADCS; IMMUNOGLOBULIN REPLACEMENT THERAPY; MESOPOROUS SILICA NANOPARTICLES; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; NEONATAL FC-RECEPTOR; SINGLE-DOMAIN ANTIBODIES

Prev One:Mechanistic insights into circularization via Anabaena group I intron-based scarless circular RNA Next One:Biodegradable silica nanocapsules enable efficient nuclear-targeted delivery of native proteins for cancer therapy